Mixed results cardiovascular stem cell therapy at ESC – PMLiVE
PMLiVE |
Mixed results cardiovascular stem cell therapy at ESC
PMLiVE Two trials of stem cells in patients with heart failure have failed to meet their targets, but have yielded tantalising glimpses of clinical benefit. The studies of candidates in development at CardioCell and Celyad were presented over the weekend at … Stem–Cell Therapy Trials Miss Mark but Keep Hope Alive IV stem cell treatment safe, effective in patients with nonischemic HF CardioCell stem cells 'improve well-being' of heart failure patients … |
